SEC Info - APP Pharmaceuticals, Inc. - IPO: ‘S-1/A’ on 12/13/01

SEC Info℠

Home

Help

Please Sign In

APP Pharmaceuticals, Inc. – IPO: ‘S-1/A’ on 12/13/01

On: Thursday, 12/13/01 · Accession #: 898430-1-503863 · File #: 333-70900

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/13/01  APP Pharmaceuticals, Inc.         S-1/A                  7:709K                                   Donnelley R R & S… 05/FA

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Amendment #3 to Form S-1                             127    667K 
 2: EX-1.1      Underwriting Agreement                                30    135K 
 3: EX-4.2      Specimen Stock Certificate of the Registrant           1      6K 
 4: EX-5.1      Opinion of Morrison & Foerster LLP                     1      8K 
 5: EX-10.11    License Agreement, Dated 10/20/2001                   32    114K 
 6: EX-10.12    Manufacturing Agreement, Dated 10/20/2001             24     80K 
 7: EX-10.17    Group Purchasing Agreement, Dated 12/12/97            22     84K

Filing Submission 0000898430-01-503863 – SGML Text

Original SGML Text submitted by:	Donnelley Financial Solutions 05/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 709K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20011214-180221	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20011214-180221	 ⇐ Metadata from SEC Info (ET)
<ACCESSION-NUMBER>		0000898430-01-503863
<TYPE>				S-1/A
<PUBLIC-DOCUMENT-COUNT>		7
<FILING-DATE>			20011213

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		AMERICAN PHARMACEUTICAL PARTNERS INC /CA/
<CIK>				0001141399
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			680389419  ⇒ 68-0389419 or 680-38-9419
<STATE-OF-INCORPORATION>	CA
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			S-1/A
<ACT>				33
<FILE-NUMBER>			333-70900
<FILM-NUMBER>			1812949
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			10866 WILSHIRE BLVD
<STREET2>			SUITE 1270
<CITY>				LOS ANGELES
<STATE>				CA
<ZIP>				90024
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			10866 WILSHIRE BLVD
<STREET2>			SUITE 1270
<CITY>				LOS ANGELES
<STATE>				CA
<ZIP>				90024
</MAIL-ADDRESS>
</FILER>

<DOCUMENT>
<TYPE>		S-1/A
<SEQUENCE>	1
<FILENAME>	ds1a.txt
<DESCRIPTION>	AMENDMENT #3 TO FORM S-1
<TEXT>
       Show <TEXT>: 8,731 lines (widest: 130 characters) - 469K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-1.1
<SEQUENCE>	3  ⇒ 2  ⇐ Document/Exhibit 2
<FILENAME>	dex11.txt
<DESCRIPTION>	UNDERWRITING AGREEMENT
<TEXT>
       Show <TEXT>: 1,566 lines (widest: 80 characters) - 99K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.2
<SEQUENCE>	4  ⇒ 3  ⇐ Document/Exhibit 3
<FILENAME>	dex42.txt
<DESCRIPTION>	SPECIMEN STOCK CERTIFICATE OF THE REGISTRANT
<TEXT>
       Show <TEXT>: 45 lines (widest: 111 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-5.1
<SEQUENCE>	5  ⇒ 4  ⇐ Document/Exhibit 4
<FILENAME>	dex51.txt
<DESCRIPTION>	OPINION OF MORRISON & FOERSTER LLP
<TEXT>
       Show <TEXT>: 40 lines (widest: 80 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.11
<SEQUENCE>	6  ⇒ 5  ⇐ Document/Exhibit 5
<FILENAME>	dex1011.txt
<DESCRIPTION>	LICENSE AGREEMENT, DATED 10/20/2001
<TEXT>
       Show <TEXT>: 1,740 lines (widest: 80 characters) - 93K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.12
<SEQUENCE>	7  ⇒ 6  ⇐ Document/Exhibit 6
<FILENAME>	dex1012.txt
<DESCRIPTION>	MANUFACTURING AGREEMENT, DATED 10/20/2001
<TEXT>
       Show <TEXT>: 1,226 lines (widest: 80 characters) - 63K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.17
<SEQUENCE>	8  ⇒ 7  ⇐ Document/Exhibit 7
<FILENAME>	dex1017.txt
<DESCRIPTION>	GROUP PURCHASING AGREEMENT, DATED 12/12/97
<TEXT>
       Show <TEXT>: 1,165 lines (widest: 107 characters) - 63K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0000898430-01-503863 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

APP Pharmaceuticals, Inc. – IPO: ‘S-1/A’ on 12/13/01

On: Thursday, 12/13/01 · Accession #: 898430-1-503863 · File #: 333-70900

Previous ‘S-1’: ‘S-1/A’ on 12/11/01 · Latest ‘S-1’: This Filing

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1Filing Table of Contents

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents